Therapeutic efficacies of two newly isolated Edwardsiella phages against Edwardsiella piscicida infection

The spread of multi-drug resistant (MDR) bacteria has posed a threat to the development of aquaculture. Due to its effective bactericidal ability, phage therapy has been considered as an alternative to antibiotics to reduce infection caused by MDR bacteria. In this study, two Edwardsiella piscicida phages were newly-isolated and characterized to prevent or treat infection in aquaculture. The phages were designated as vB_EpM_ZHS and vB_EpP_ZHX belonging to Myoviridae and Podoviridae families, respectively, in terms of genome sequence and morphology analyses. The combination of vB_EpM_ZHS and vB_EpP_ZHX improved the therapeutic efficacy both in vitro and in vivo. The phage cocktail significantly inhibited bacterial growth in vitro and decreased approximately 40% of mortality rate and an order of magnitude of bacterial burden in zebrafish and turbot infected by E. piscicida. Moreover, the phage cocktail increased transcription levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-12 (IL-12), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) and alleviated inflammatory levels in the hindgut and spleen of turbots. The results indicate that the phage has a promising potential for therapeutic use against E. piscicida as the antimicrobial alternative to antibiotics in aquaculture.

Automated summary

This study isolated and characterized two newly-identified Edwardsiella piscicida phages, which show promising potential for therapeutic use in aquaculture to prevent and treat infections caused by multi-drug resistant bacteria. The combined use of these phages significantly improves therapeutic efficacy and reduces disease transmission and inflammatory response.